Jeffrey S. Durmer, MD, Ph.D.

Sleepopolis may earn a commission on sales through our affiliate links in this article. This commission allows us to run our testing lab and continue to bring our readers the most comprehensive information on sleep and related products. See our disclosures.

Jeffrey S. Durmer, MD, PhD

Dr. Jeffrey Durmer is a systems neuroscientist, neurologist and sleep medicine physician with particular expertise in technology enabled sleep-health delivery systems. He began his career at the University of Pennsylvania studying the neurophysiology of central nervous systems that generate sleep and circadian rhythms in animals. Currently, he is co-founder, Chief Medical Officer of Nox Health, a Georgia-based sleep healthcare technology firm.

At Nox Health, he oversees the development of innovative medical systems that
provide scalable solutions using platform-based technologies to access, diagnose, treat and manage sleep problems and disorders in large populations. Prior to Nox Health, he co-founded FusionSleep, an Atlanta-based AASM accredited multi-disciplinary sleep medicine program that continues to serve tens-of-thousands of children and adults with sleep disorders. He was also director of the Emory University Sleep Laboratory and Pediatric Sleep Medicine Program where he trained graduate students, medical students, residents and fellows.

Dr. Durmer is a co-investigator for the NIH-funded Sleep SMART research trial together with the University of Michigan & the NIH StrokeNet consortium to determine if treating obstructive sleep apnea protects individuals from the occurrence of stroke. He is a collaborator and advisor to the Virginia Tech Transportation Institute on multiple studies, most recently the ongoing OSAFE investigation to determine the impact of obstructive sleep apnea therapy on the safety of professional truck drivers. Dr. Durmer provides scientific and clinical guidance for multiple sleep-related organizations involved in the healthcare technology, pharmaceutical, and clinical science/practice arenas.

He has published multiple medical textbook chapters, original research papers and
abstracts. His collaboration with multiple international clinical research teams led to the development of medical criteria used to diagnose and treat Restless Legs Syndrome in adults and children. Dr. Durmer is past-President of the Georgia Association of Sleep Professionals and three-term member of the Medical & Scientific Advisory Board for the Restless Legs Foundation, and currently serves on the pediatric RLS subcommittee for the Foundation. He serves as the Sleep Performance Director for the United States Olympic Weightlifting team and multiple other sports organizations including the NFL’s Atlanta Falcons and the NCAA DIII Championship Emory University Swimming & Diving team. In addition, he is the appointed Sleep Medicine advisor to the Federal Aviation Administration.

For more information about Jeffrey S. Durmer, visit his website.

About Sleepopolis

Sleepopolis is a property dedicated to helping people around the world get a better night’s sleep. We cover a wide range of sleep and recovery topics, including in-depth reviews on mattresses and other sleep products, sleep industry news and events, and research-focused content on sleep science and wellbeing (which we call Sleep Education). Our goal is to help readers make better, more informed decisions regarding their sleep and rest.

Our writers specialize in sleep topics, and the majority of our reviews focus on their in-person experiences with and testing of products. In order to promote accuracy in our content, Sleepopolis features a robust Expert Network to help verify much of the content you see on the site, including both reviews and Sleep Education. This network consists of board-certified physicians, physical therapists, other medical professionals, researchers, and innovators in the sleep space. Content that has been expert verified is indicated with a blue checkmark at the top of those pages. We also work to keep our content up-to-date and indicate the day of the most recent editorial updates at the top of our articles.